Literature DB >> 18429497

Immunosuppression routed via the kynurenine pathway: a biochemical and pathophysiologic approach.

Alvaro González1, Nerea Varo, Estibaliz Alegre, Angel Díaz, Ignacio Melero.   

Abstract

In the past years, it has been shown that kynurenines pathway is a regulator of both the innate and the adaptive immune responses. Particularly, the initial enzyme of this pathway, indoleamine 2,3-dioxygenase (IDO), is implicated in maintaining tolerance during pregnancy, and also can be expressed in tumors to avoid the immune attack. In this chapter, we will describe how the kynurenine pathway affects the immune system with important implications both in physiology and in pathology. The incorrect activation or blockade suppressive properties of the kynurenine pathway are also implicated in a number of other diseases such as AIDS or autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18429497     DOI: 10.1016/s0065-2423(07)00007-8

Source DB:  PubMed          Journal:  Adv Clin Chem        ISSN: 0065-2423            Impact factor:   5.394


  18 in total

1.  Human pancreatic cancer tumors are nutrient poor and tumor cells actively scavenge extracellular protein.

Authors:  Jurre J Kamphorst; Michel Nofal; Cosimo Commisso; Sean R Hackett; Wenyun Lu; Elda Grabocka; Matthew G Vander Heiden; George Miller; Jeffrey A Drebin; Dafna Bar-Sagi; Craig B Thompson; Joshua D Rabinowitz
Journal:  Cancer Res       Date:  2015-02-01       Impact factor: 12.701

Review 2.  The kynurenine system and immunoregulation.

Authors:  Yvette Mándi; László Vécsei
Journal:  J Neural Transm (Vienna)       Date:  2011-07-09       Impact factor: 3.575

3.  Gas chromatography/tandem mass spectrometry detection of extracellular kynurenine and related metabolites in normal and lesioned rat brain.

Authors:  Francesca M Notarangelo; Hui-Qiu Wu; Anthony Macherone; David R Graham; Robert Schwarcz
Journal:  Anal Biochem       Date:  2011-12-28       Impact factor: 3.365

Review 4.  Lysine metabolism in mammalian brain: an update on the importance of recent discoveries.

Authors:  André Hallen; Joanne F Jamie; Arthur J L Cooper
Journal:  Amino Acids       Date:  2013-09-17       Impact factor: 3.520

5.  A community-based study on determinants of circulating markers of cellular immune activation and kynurenines: the Hordaland Health Study.

Authors:  D Theofylaktopoulou; Ø Midttun; A Ulvik; P M Ueland; G S Tell; S E Vollset; O Nygård; S J P M Eussen
Journal:  Clin Exp Immunol       Date:  2013-07       Impact factor: 4.330

Review 6.  Of mice, rats and men: Revisiting the quinolinic acid hypothesis of Huntington's disease.

Authors:  Robert Schwarcz; Paolo Guidetti; Korrapati V Sathyasaikumar; Paul J Muchowski
Journal:  Prog Neurobiol       Date:  2009-04-24       Impact factor: 11.685

7.  Inflammatory-induced hibernation in the fetus: priming of fetal sheep metabolism correlates with developmental brain injury.

Authors:  Matthias Keller; David P Enot; Mark P Hodson; Emeka I Igwe; Hans-Peter Deigner; Justin Dean; Hayde Bolouri; Henrik Hagberg; Carina Mallard
Journal:  PLoS One       Date:  2011-12-29       Impact factor: 3.240

8.  Inflammatory Pathways in Psychiatric Disorders: The case of Schizophrenia and Depression.

Authors:  Tami Feng; Ashutosh Tripathi; Anilkumar Pillai
Journal:  Curr Behav Neurosci Rep       Date:  2020-07-26

9.  Kynurenine pathway inhibition reduces central nervous system inflammation in a model of human African trypanosomiasis.

Authors:  Jean Rodgers; Trevor W Stone; Michael P Barrett; Barbara Bradley; Peter G E Kennedy
Journal:  Brain       Date:  2009-03-31       Impact factor: 13.501

Review 10.  Kynurenines and Multiple Sclerosis: The Dialogue between the Immune System and the Central Nervous System.

Authors:  Cecilia Rajda; Zsófia Majláth; Dániel Pukoli; László Vécsei
Journal:  Int J Mol Sci       Date:  2015-08-06       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.